Dr. Hesham Abboud – Symptomatic Management of Autoimmune Encephalitis
March 3, 2025
We look forward to Dr. Hesham Abboud, MD, PhD, joining our May 2025 AEA Provider Monthly Education Series and presenting on symptomatic management of autoimmune encephalitis.
Dr. Abboud is the Director of Neuroimmunology at University Hospitals Cleveland Medical Center and Associate Professor of Neurology at Case Western Reserve University. He founded and currently runs a specialized autoimmune encephalitis clinic and a busy inpatient consultation service for autoimmune neurological patients at University Hospitals of Cleveland
The session is scheduled for May 15, 2025 at 3:00 PM Eastern Time.
Members of the AEA Medical Advisory Board and Clinicians Network and participating fellowship programs receive monthly emails including links to register for each session.
A recording of the didactic portion of Dr. Abbouds’ session will be posted here after the session.
Learning objectives of the session:
- Learn the most common presenting and residual symptoms of autoimmune encephalitis
- Learn therapeutic approaches to symptomatic management of autoimmune encephalitis in the acute and recovery phases of the disease
- Identify the knowledge gaps and pressing needs in autoimmune encephalitis symptom management
Links to relevant references:
- Abboud H, Probasco J, Irani SR, et al., Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management. J Neurol Neurosurg Psychiatry. 2021 Mar 1;92(8):897–907. doi: 10.1136/jnnp-2020-325302. Epub ahead of print. PMID: 33649021; PMCID: PMC8292591.
- Matricardi S, Casciato S, Bozzetti S, et al., Immune Epilepsies Study Group of the Italian League Against Epilepsy. Epileptic phenotypes in autoimmune encephalitis: from acute symptomatic seizures to autoimmune-associated epilepsy. J Neurol Neurosurg Psychiatry. 2022 Jul 25:jnnp-2022-329195. doi: 10.1136/jnnp-2022-329195. Epub ahead of print. PMID: 35879055.
- Ali F, Wijdicks EF. Treatment of Movement Disorder Emergencies in Autoimmune Encephalitis in the Neurosciences ICU. Neurocrit Care. 2020 Feb;32(1):286-294. doi: 10.1007/s12028-019-00875-5. PMID: 31732848.
- Mohammad SS, Jones H, Hong M, Nosadini M, Sharpe C, Pillai SC, Brilot F, Dale RC. Symptomatic treatment of children with anti-NMDAR encephalitis. Dev Med Child Neurol. 2016 Apr;58(4):376-84. doi: 10.1111/dmcn.12882. Epub 2015 Aug 28. PMID: 26330176.
- Thakolwiboon S, Gilligan M, Orozco E, et al., Autoimmune encephalitis: recovery, residual symptoms and predictors of long-term sequelae. J Neurol Neurosurg Psychiatry. 2025 Jan 19:jnnp-2024-334957. doi: 10.1136/jnnp-2024-334957. Epub ahead of print. PMID: 39832911.
- Abboud H, Briggs F, Buerki R, et al., Residual symptoms and long-term outcomes after all-cause autoimmune encephalitis in adults. J Neurol Sci. 2022 Mar 15;434:120124. doi: 10.1016/j.jns.2021.120124. Epub 2021 Dec 31. PMID: 34998237.
Learn more about Dr. Abboud.
Learn more about the AEA Provider Monthly Didactic + Case Discussion Series.
Click here and FILTER BY “AEA Monthly Didactic” to access all didactic recordings.
